Translational Hematology Cluster (THC)
The Translational Hematology Cluster (THC) consists of five research groups: the Translational Signaling group (P.I. Prof. Stein Ove Døskeland), the Nanomedicine group (P.I. Prof. Lars Herfindal), the Leukemia Research group (P.I. Prof. Øystein Bruserud), the Translational Hemato-Oncology group (P.I. Prof. Bjørn Tore Gjertsen) and the Translational Molecular Imaging in Cancer group (P.I. Prof. Emmet Mc Cormack).
Please save the date 17th of December for the next THC-seminar entitled “Let´s talk about drugs – from basic science to clinical trials”. More information can be found under the banner “Calendar”.
The aim with the THC seminar series is to improve collaboration across research groups, and to provide an open venue for both junior and established scientists to present and discuss their research. The THC seminars are arranged twice each year, and invited speakers give presentations about novel results and exciting, state-of-the-art experimental methods. Previous themes have been "Stem cell biology; possibilities and perspectives", "Genetic-proteomics approaches", "The microenvironment", “Proteomic approaches in hematology research” and “Metabolomics in Hematological Malignancies”.
Committee members are Rakel Brendsdal Forthun, Tuyen Thi Van Hoang, Ina Nepstad and Kimberley Hatfield.
Everyone is welcome to participate!
Contact person: Rakel.Forthun@uib.no
